Novo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials - The Guardian

[unable to retrieve full-text content]

1. Novo Nordisk shares slide after Ozempic pill fails in Alzheimer’s trials  The Guardian
2. Novo Nordisk shares slump after drug failure in Alzheimer’s trial  Financial Times
3. Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says  CNN
4. Ozempic-maker's shares plunge after failed Alzheimer's trial  Sky News
5. Weight-loss drugs: What other conditions are they being used and tested for?  Reuters

https://news.google.com/rss/articles/CBMisAFBVV95cUxQMURjVC1jaHNqZ0FKem9MUGdZRmRlYlJ2UlJoS0xubFJmTmhHcVhuYkhLRVpRY3g2bXoxVzZGYk1FZG9jWWJTckpXZE93aHlkVzM3d1FRejlJYnJlWmhtOEw0aFNFTkdPOENXV09ZUDllSG9OWGphNVZCcFczbmxZVHJOT1hyNlI2Rm9xazh5VkVJU2tVcXE5X1QzUTBzNnF6enJzRjhHclpzMDFQZlhJNA?oc=5

2025-11-24 13:45:00Z
CBMisAFBVV95cUxQMURjVC1jaHNqZ0FKem9MUGdZRmRlYlJ2UlJoS0xubFJmTmhHcVhuYkhLRVpRY3g2bXoxVzZGYk1FZG9jWWJTckpXZE93aHlkVzM3d1FRejlJYnJlWmhtOEw0aFNFTkdPOENXV09ZUDllSG9OWGphNVZCcFczbmxZVHJOT1hyNlI2Rm9xazh5VkVJU2tVcXE5X1QzUTBzNnF6enJzRjhHclpzMDFQZlhJNA